The estimated Net Worth of David Bharucha is at least $14.5 Тысяча dollars as of 1 December 2022. David Bharucha owns over 10,000 units of Milestone Pharmaceuticals Inc stock worth over $14,500 and over the last 3 years David sold MIST stock worth over $0.
Sign up
David Bharucha MIST stock SEC Form 4 insiders trading
David has made over 1 trades of the Milestone Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently David bought 10,000 units of MIST stock worth $47,400 on 1 December 2022.
The largest trade David's ever made was buying 10,000 units of Milestone Pharmaceuticals Inc stock on 1 December 2022 worth over $47,400. On average, David trades about 3,333 units every 0 days since 2022. As of 1 December 2022 David still owns at least 10,000 units of Milestone Pharmaceuticals Inc stock.
You can see the complete history of David Bharucha stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's David Bharucha's mailing address?
David's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, A8, H4M 2X6.
Insiders trading at Milestone Pharmaceuticals Inc
Over the last 6 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic... и Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.
What does Milestone Pharmaceuticals Inc do?
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
What does Milestone Pharmaceuticals Inc's logo look like?
Complete history of David Bharucha stock trades at Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc executives and stock owners
Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Joseph G. Oliveto,
CEO, Pres & Director -
Amit Hasija,
CFO & Exec. VP of Corp. Devel. -
Dr. Francis Plat,
Chief Medical Officer -
Lorenz Muller,
Chief Commercial Officer -
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
Chief Medical Advisor & Member of the Scientific Advisory Board -
Jeff Nelson,
Chief Operating Officer -
Dr. Philippe Douville,
Founder, Strategic Advisor & Member of Scientific Advisory Board -
Richard C Pasternak,
Director -
Debra K. Liebert,
Director -
Paul F Truex,
Director -
Joseph C Papa,
-
Amit Hasija,
CFO & EVP of Corp. Development -
Seth H. Z. Fischer,
-
Timothy Maness,
Chief Accounting Officer -
Philippe Douville,
Chief Scientific Officer -
De Solidarite Des Travaille...,
10% owner -
Holdings A/S Novo,
10% owner -
Investments, Lpwong Roderic...,
-
Capital Inc. Bdc,
10% owner -
Francis Plat,
Chief Medical Officer -
Joseph Oliveto,
President and CEO -
Lorenz Muller,
Chief Commercial Officer -
Paul R Edick,
Director -
Michael John Tomsicek,
-
Stuart Duty,
-
David Bharucha,
Chief Medical Officer -
Jeffrey Edward Nelson,
Chief Operating Officer -
Lisa M. Giles,
-
Robert James Wills,